Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Anavex Life Sciences Corp AVXL

Anavex Life Sciences Corp. is a clinical-stage biopharmaceutical company. The Company is engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system (CNS) diseases with unmet need. The Company analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Current News (NDAQ:AVXL)

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Anavex Life Sciences Corp. with Losses to Contact the Firm

Newsfile 13 hours ago

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of May 13, 2024 in Anavex Life Sciences Corporation Lawsuit - AVXL

Accesswire 16 hours ago

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Anavex Life Sciences Corporation (AVXL) Shareholders

Accesswire 16 hours ago

INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in Anavex Life Sciences Corp. with Losses of $100,000 to Contact the Firm

Accesswire 17 hours ago

Contact The Gross Law Firm by May 13, 2024 Deadline to Join Class Action Against Anavex Life Sciences Corporation(AVXL)

PR Newswire 18 hours ago

Levi & Korsinsky Reminds Anavex Life Sciences Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 13, 2024 - AVXL

Accesswire 19 hours ago

AVXL LAWSUIT ALERT: Levi & Korsinsky Notifies Anavex Life Sciences Corporation Investors of a Class Action Lawsuit and Upcoming Deadline

Accesswire 19 hours ago

AVXL SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Reminds Anavex Life Sciences Corp. Investors to Join the Class Action Lawsuit!

Accesswire 19 hours ago

Levi & Korsinsky Notifies Anavex Life Sciences Corporation Investors of a Class Action Lawsuit and Upcoming Deadline - AVXL

Accesswire 1 day ago

Bullboard Posts (NDAQ:AVXL)

Not a lot of respect here….

For their data.  Seems like everyone is doubting efficacy.  But the approved products are NG also?  Well if the pharma...
hoffbag - November 25, 2023

$AVXL ANAVEX 2-73: A POTENTIAL BLOCKBUSTER DRUG IN THE MAKIN

$AVXL ANAVEX 2-73: A POTENTIAL BLOCKBUSTER DRUG IN THE MAKING!   https://www.aviseanalytics.com/anavex2-73-a-potential...
AviseAnalytics - June 30, 2021

AVXL 5 MOST PROMISING ALZHEIMER’S DISEASE STOCK!

5 MOST PROMISING ALZHEIMER’S DISEASE STOCK! https://www.aviseanalytics.com/5-most-promising-alzheimers-disease-stock/ ...
AviseAnalytics - June 22, 2021

ALL ABOARD

Dont miss this train leaving the station.............
billybob22 - February 4, 2021

End of Month - September 2020

End of the Month (EOM) report for November 2020 for Anavex Life Sciences Corp. - AVXL closed on 10/30/2020 at US$5.33 AVXL closed on 10...
R_J_ - December 2, 2020

End of Month - October 2020

End of the Month (EOM) report for October 2020 for Anavex Life Sciences Corp. - AVXL closed on 10/30/2020 at US$5.90 AVXL closed on 09/30...
R_J_ - October 31, 2020